A 13-bp deletion in αIIb gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia
Open Access
- 24 November 2005
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (12) , 2764-2772
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Talin controls integrin activationBiochemical Society Transactions, 2004
- A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formationJournal of Thrombosis and Haemostasis, 2004
- Critical residues for ligand binding in blade 2 of the propeller domain of the integrin αIIb subunitThrombosis and Haemostasis, 2004
- Amino Acid Residues in the αIIb Subunit That Are Critical for Ligand Binding to Integrin αIIbβ3 Are Clustered in the β-Propeller ModelJournal of Biological Chemistry, 2001
- Crystal Structure of the Extracellular Segment of Integrin αVβ3Science, 2001
- Using linked markers to infer the age of a mutationHuman Mutation, 2001
- Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17British Journal of Haematology, 1998
- Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.Journal of Clinical Investigation, 1997
- Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: Involvement of platelet GPIIb-IIIa and tumor cell ?v integrinsInternational Journal of Cancer, 1997
- Inherited Bleeding Disorders in the Eastern Province of Saudi ArabiaActa Haematologica, 1988